SNo Title of the Paper Status of Publication Download
1 Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage Published in Journal of Travel Medicine
Oxford University Press
2 Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2 Published in Journal of Travel Medicine
Oxford University Press
3 Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travellers from South Africa and Tanzania to India Published in Travel Medicine & Infectious Diseases
Elsevier, Netherlands
4 An epidemiological analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India Published in Viruses
MDPI, Switzerland
5 Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees Pre-proof published in Clinical Infectious Diseases
Oxford University Press
6 Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine Published in Journal of Travel Medicine
7 Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters Published in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA
8 Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1 Accepted in Clinical Infectious Diseases
Oxford University Press
9 Detection of SARS-CoV-2 variants in India from UK returnees Accepted in Infection
Springer, Germany
10 SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant Under review in Clinical Infectious Diseases
Released on BioRxiv
11 Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model Under review in Scientific reports
Released on BioRxiv
12 Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travellers Under review in Travel Medicine & Infectious Diseases
Released on BioRxiv
13 Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant Under review in Scientific Reports
Released on BioRxiv
14 Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model Under review in Journal of Infection and Public Health
Released on BioRxiv
15 Detection of SARS CoV-2 VUI-202102/03 variant (B.1.525) from India. Under review in Indian Journal of Medical Research
16 Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin Published in Journal of Travel Medicine
17 Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19 recovered vaccinated individuals Published in Journal of Travel Medicine
Oxford University Press
18 Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/COVAXIN Published in Journal of Travel Medicine
Oxford University Press
19 Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India Published in Viruses
MDPI, Switzerland
20 SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters Published in Viruses
MDPI, Switzerland
21 Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152 BioRxiv preprint
22 Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime medRxiv preprint
23 Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021 Published in Journal of Infection

© Copyright 2020 by ICMR. All Rights Reserved. Designed by BMI division ICMR.   |   Website Policies